Position in CTMX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$17,545,185
+$7,832,109 QoQ
Shares Held
4,678,716
+126.4% QoQ
Ownership
2.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 178 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. CTMX ranks #147 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CTMX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,545,185 | 4,678,716 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $9,713,076 | 2,066,612 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,499,337 | 1,525,666 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $5,006,060 | 1,569,298 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,961,549 | 1,745,176 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $545,660 | 857,958 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $840,111 | 815,643 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $948,166 | 803,531 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $938,787 | 769,499 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,642,407 | 753,398 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,089,113 | 702,654 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $872,482 | 676,343 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,107,829 | 644,087 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $969,885 | 642,308 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $964,920 | 603,075 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $851,803 | 587,451 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,067,008 | 583,065 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,803,895 | 1,050,148 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,082,757 | 1,173,847 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,716,492 | 1,123,083 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,298,553 | 1,153,010 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,329,987 | 1,077,618 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,966,956 | 758,314 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,008,539 | 753,164 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,905,045 | 708,889 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,408,784 | 705,187 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||